NEW

UVDI-360 Room Sanitizer Inactivates SARS-CoV-2 at 12 Feet Distance in 5 Minutes

UltraViolet Devices Inc. (UVDI) has announced that its UVDI-360 Room Sanitizer achieved greater than 99.99%, or 4log10, inactivation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in 5 minutes at a distance of 12 feet (3.65 meters).

oneSOURCE Creates Free Resource Page with Up-to-Date COVID-19 Vaccine Information

Today, oneSOURCE, an RLDatix company and leading healthcare management solution, announced a new COVID-19 vaccine resource page to assist healthcare professionals during the initial administration phases of the vaccine.

STERIS to Acquire Cantel Medical

STERIS plc and Cantel Medical Corp. announced that STERIS has signed a definitive agreement to acquire Cantel, through a U.S. subsidiary. Cantel is a global provider of infection prevention products and services primarily to endoscopy and dental Customers.

NEC Releases ‘WISE VISION Endoscopy’ in Europe and Japan

NEC Corporation has announced the development of “WISE VISION Endoscopy,” an AI diagnosis-support medical device software for colonoscopies, which is being released in Japan and is expected to soon be available in Europe.

ASCA Addresses Elective Surgery and COVID-19

With the growing concern that hospitals may be overwhelmed by a surging number of patients with COVID-19, the Centers for Disease Control and Prevention (CDC) has recommended that some inpatient surgeries be shifted to outpatient settings, when feasible. However, there has been conflicting guidance about elective surgeries that indicates additional guidance is warranted.

The Ambulatory Surgery Center Association (ASCA) has consulted with clinical experts in our community and the consensus position is that ASCs can continue to provide safe surgical care for patients whose condition cannot wait until hospitals return to normal operations. As a critical component of the healthcare system, we are keenly aware of how our actions can materially impact the health of the communities that we serve and recommend the following guidelines for the continuation of urgent/needed care in our ASCs:

  • Keeping facilities open for elective urgent surgeries
  • Assessing and optimizing patients’ medical and social risk factors for planned surgeries, and postponing cases where indicated, including:
    • reassessing and reprioritizing all currently scheduled cases and postponing based on the current and projected COVID-19 cases in the facility and the surrounding area and when doing so will not result in significant medical deterioration or materially impact the patient’s prognosis, morbidity or treatment plan
    • Acknowledging that every patient encounter is unique and postponement decisions must represent a joint decision between the treating clinician and the patient
  • Implementing rigorous screening for patients and visitors prior to entering the facility
  • Maintaining a safe environment for patients, employees and visitors, including adherence to social distancing recommendations
  • Implementing enhanced cleaning as directed by CDC guidelines
  • Working within the capacity of the supply chain to ensure that hospitals have priority for necessary equipment/supplies
  • Collaborating with hospitals and health systems to coordinate care based on each community’s individual needs.

ASCs can serve as alternative settings that provide surgical care for those patients who would suffer from a delay, while allowing our local hospital partners to create the incremental capacity needed during these dynamic times. As the pandemic progresses, we will continue to assess our approach, in coordination with experts throughout the healthcare system, to best serve the needs of patients and communities.

The ASC community stands ready to work with federal officials, state and local governments, and all our colleagues in the healthcare system to provide needed care during these challenging times.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X